&nbsp;

Drugs Used:

palbociclib,

letrozole

Quick Link(s):

Regimen Monograph

Sep 2025

Regimen

LETRRIBO

Cancer Type:

Breast

Intent: Palliative

Funding:

Exceptional Access Program

ribociclib - For the treatment of patients with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER 2)-negative, unresectable locally advanced or metastatic breast cancer in combination with an aromatase inhibitor or fulvestrant according to clinical criteria

ODB - General Benefit

letrozole

Drugs Used:

letrozole,

ribociclib

Quick Link(s):

Regimen Monograph

Sep 2025

Regimen

LARO

Cancer Type:

Breast,

Central Nervous System,

Endocrine,

Adrenal,

Neuroendocrine,

Pancreatic Neuroendocrine,

Parathyroid,

Thymoma,

Thyroid,

Gastrointestinal,

Anus,

Colorectal,

Esophagus,

Gastric / Stomach,

Gastrointestinal Stromal Tumours,

Hepatobiliary / Liver / Bile Duct,

Mesothelioma (Peritoneal),

Neuroendocrine (GI),

Pancreas,

Rectal,

Small bowel and appendix,

Genitourinary,

Bladder / Urothelial,

Penile,

Prostate,

Renal cell / Kidney,

Testis,

Gynecologic,

Cervix,

Endometrial,

Germ Cell,

Gestational Trophoblastic Disease,

Ovary,

Uterine Sarcoma,

Vagina,

Vulva,

Head and Neck,

Larynx,

Nasopharynx,

Oral,

Paranasal Sinus,

Pharynx,

Salivary Gland,

Squamous Cell,

Kaposi's Sarcoma,

Lung,

Mesothelioma (Pleural),

Neuroendocrine (Lung),

Non-Small Cell,

Small Cell,

Sarcoma,

Desmoid Tumour,

Ewing's,

Ewing's and Soft Tissue,

GIST,

Giant Cell Tumour,

Kaposi's Sarcoma,

Osteogenic / Bone,

Soft Tissue,

Uterine,

Wilm's Tumour,

Skin,

Basal Cell,

Melanoma,

Merkel Cell,

Squamous Cell,

Unknown Primary

Intent: Palliative

Funding:

Exceptional Access Program

larotrectinib - For the treatment of unresectable locally advanced, or metastatic solid tumours with neurotrophic tyrosine receptor kinase (NTRK) gene fusion, according to clinical criteria

Drugs Used:

larotrectinib

Quick Link(s):

Regimen Monograph

Sep 2025

Drug

luspatercept

Other Name(s): Reblozyl®

Quick Link(s):

Drug Monograph, Patient Info Sheet

Sep 2025

Drug

leuprolide

Other Name(s): Lupron Depot® , Eligard®

Quick Link(s):

Drug Monograph, Patient Info Sheet

Updated

Apr 2026

Regimen

LPRL

Cancer Type:

Genitourinary,

Prostate

Intent: Neoadjuvant, Adjuvant, Palliative

Funding:

ODB - General Benefit

leuprolide

Drugs Used:

leuprolide

Quick Link(s):

Regimen Monograph

Updated

Apr 2026

Drug

lenvatinib

Other Name(s): Lenvima®

Quick Link(s):

Drug Monograph, Patient Info Sheet

Updated

Apr 2026

Regimen

LENV

Cancer Type:

Endocrine,

Thyroid

Intent: Palliative

Funding:

Exceptional Access Program

lenvatinib - For the treatment of patients with locally recurrent or metastatic, progressive, radioactive-iodine-refractory differentiated thyroid cancer (DTC) according to criteria

Drugs Used:

lenvatinib